Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,038 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Navigating India's Regulatory Landscape: The New Drugs And Clinical Trials Rules, 2019

    India's pharmaceutical industry has long been a global leader, recognized for its innovation and contributions to improving healthcare accessibility.
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Telemedicine Practice Through Consultation Centres/Clinics In India: Guidelines And Regulatory Approvals

    Onset of COVID 19 pandemic created an urgency in provision of medical services to remote areas through digital and online means and adoption of technology.
    IndiaFood, Drugs, Healthcare, Life Sciences
    LexCounsel
LexCounsel
  • Article

    COVID, Ventilators & Patents

    It was March 11, 2020 that world got one of the biggest jolt of the century when World Health Organization's Director-General Tedros Adhanom announced that the COVID-19 outbreak, that started in December 2019 ...
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Patent Infringements And Their Types

    Patent is one of the most important forms of Intellectual Property (IP). The term of a patent is typically 20 years from the Priority date of the application.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Patenting Of Nanobiotechnology Inventions: Exploring The Challenges Under The Indian Patent Law

    Nanotechnology is a vast field which includes a range of technologies at the nano scale, being applied to pharmaceuticals, biotechnology, genomics, neuroscience, robotics and information...
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Pharmaceutical Patent Architecture In India In Light Of TRIPS Obligations

    India's pharmaceutical patent system navigates the delicate balance between protecting innovation and ensuring affordable access to life-saving medicines for millions living in poverty. Through mechanisms like compulsory licensing and restrictions on patent evergreening, the country attempts to honor its TRIPS obligations while maintaining its role as the "Pharmacy of the World." How effectively do these legal safeguards reconcile the competing interests of global pharmaceutical giants and public health nee
    IndiaIntellectual Property
    Maheshwari & Co. Advocates & Legal Consultants
    Maheshwari & Co. Advocates & Legal Consultants
  • Article

    Strict Examination Criteria Needed For Drug Patents

    Patentability of pharmaceutical drugs and other issue associated with the patent have been a moot point all over the world.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    NPCR Notice To Cadbury Bournvita Sheds Light On Advertisement Standards In India

    This conundrum provides a viable opportunity to delve into the advertisement guidelines prescribed by the Food and Safety Standards Authority of India (FSSAI)
    IndiaMedia, Telecoms, IT, Entertainment
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    CCI Finds Alkem And Macleods Limiting Supplies To Stockists Under Duress Of Bengal Chemists Associations And District Associations

    By way of order dated 12.03.2020, the Competition Commission of India ("CCI/Commission") in three separate cases, found the Bengal Chemist and Druggist Association (BCDA)...
    IndiaAntitrust/Competition Law
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Article

    CCI Releases Its Findings Of The Market Study On The Pharmaceutical Sector In India

    On November 18, 2021, the Competition Commission of India ("CCI") published the findings of its market study ("Study") on the pharmaceutical ("Pharma") sector in India.
    IndiaAntitrust/Competition Law
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    From Cart To Court - Mitigating Legal Risks Of Non-compliance Within India's Food Delivery Landscape

    In July 2025, the Food Safety and Standards Authority of India (FSSAI) released a statement after a confidential meeting with leading food delivery services including Swiggy, Zomato, Amazon, and Flipkart .
    IndiaConsumer Protection
    Legitpro Law
    Legitpro Law
  • Article

    When Promotion Becomes Liability: FSSAI’s Warning To Food Influencers In India

    India's food safety regulator has issued a stark warning to celebrities and social media influencers: verify health and nutritional claims before promoting food products, or face potential legal consequences. As influencer advertising violations surge to over 21% of all advertising complaints, the question of accountability has moved from public backlash to formal regulatory scrutiny, with recent show-cause notices issued to major Bollywood stars.
    IndiaConsumer Protection
    Global Advertising Lawyers Alliance (GALA)
    Global Advertising Lawyers Alliance (GALA)
  • Article

    Cosmetics (Amendment) Rules, 2025: Enhancing Labelling, Licensing, And Oversight

    The Cosmetics (Amendment) Rules, 2025, notified in the Gazette of India on 29 July 2025, mark a measured yet meaningful shift in India's regulatory approach to cosmetics. Introduced under the Drugs and Cosmetics Act, 1940...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Is Your "Herbal Tea" Legally "Tea"? Fssai Issues Clarification

    On December 24, 2025, the Food Safety and Standards Authority of India (FSSAI) issued a regulatory advisory (RCD-02004/7/2025) directing food business operators, beverage manufacturers, brand owners, advertisers, and e-commerce platforms to desist from using the term "tea" for beverages that are not derived from the Camellia sinensis plant.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Measures Taken By CDSCO Under D&C Rule To Ensure Quality Of Drugs In The Year 2018

    Central Drugs Standard Control Organization, in coordination with concerned State Licensing Authority for action as per the provisions of Drugs & Cosmetics Act, 1940, and the Drugs & Cosmetics Rules, 1945, ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Veganism: A Step Ahead From ‘Vegetarianism'

    Veganism eliminates the usage of animal products or by-products in one's daily lifestyle, including the consumption of certain food, such as dairy produce, whey, gelatin, etc.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Spice Route Legal
    Spice Route Legal
  • Article

    Ensuring Access To Life-Saving Medicines: The Case For Compulsory Licensing In Rare Diseases

    Rare diseases pose some of the gravest challenges in healthcare. Though uncommon individually, they collectively affect millions of people worldwide
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Intellectual Property Regime In India: A Special Focus In The Context Of The Novel Coronavirus/Covid-19 Pandemic.

    This article aims to analyze the intellectual property regime in India in the context of the ongoing Novel Coronavirus/Covid-19 pandemic.
    IndiaIntellectual Property
    Karanjawala & Company
    Karanjawala & Company
  • Article

    Seed Wars: Indian Court Protects Breeders' Registered Maize Variety

    How safe is your maize? A recent injunction for infringement of a maize variety in India has given a jolt to the agricultural industry...
    IndiaIntellectual Property
    Obhan Mason
    Obhan Mason
  • Article

    Pantocid vs. Pantopacid," "Pantopacid D," "Pantopacid Sr” Sun Pharma Laboratories Ltd. v. Finecure Pharmaceuticals Ltd. & Ors

    Finecure Pharmaceuticals adopted the mark "PANTOPACID" in 2007 for a competing Pantoprazole formulation and applied to register it in April 2009, claiming a portmanteau origin ("PANTO" + "P" for Proton Pump Inhibitor + "ACID"). Sun Pharma opposed this application in October 2010, and the opposition remains pending.
    IndiaIntellectual Property
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Showing 701–720 of 1038 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics